EA Pharma is a specialized pharmaceutical company focused on gastrointestinal diseases, formed through the integration of the Eisai Group's and Ajinomoto Group's expertise. This collaboration combines over 60 years of experience in gastrointestinal health and amino acid technologies, allowing EA Pharma to establish a comprehensive value chain that encompasses research and development, production, logistics, sales, and marketing. The company aims to leverage the combined knowledge of both groups to foster innovation and enhance the development of effective treatments for gastrointestinal conditions.

In addition to its commitment to research and development, EA Pharma emphasizes the importance of providing valuable information to medical professionals. The company has created dedicated resources for healthcare providers, including doctors, pharmacists, and nurses, to ensure they have access to relevant and useful information regarding its products and services. This focus on supporting medical professionals highlights EA Pharma's dedication to improving patient care and advancing the field of gastrointestinal medicine.

Japan

EA Pharma Co., Ltd. is a pharmaceutical company that promotes drug discovery and clinical development targeting gastrointestinal diseases, particularly Inflammatory Bowel Disease (IBD). The company is focused on creating new innovation through the combined knowledge of its parent companies, Eisai Co., Ltd. and Ajinomoto Co., Inc.

EA Pharma

Company Details